You have 9 free searches left this month | for more free features.

City

Berlin (1)

Changchun (1)

Gainesville (1)

Condition

Healthy Subjects (1)

Nonalcoholic Fatty Liver Disease (NAFLD) (1)

Pharmacokinetic (1)

Type 2 Diabetes (T2DM) (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Inventiva Pharma (1)

University of Florida (1)

Collaborator

Inventiva Pharma (1)

Parexel (1)

Intervention

lanifibranor (3)

placebo (2)

moxifloxacin (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

lanifibranor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pharmacokinetic Trial in Changchun (Lanifibranor)

Active, not recruiting

Pharmacokinetic

Lanifibranor

Changchun, Jilin, China

The First Hospital of Jilin University

Nov 13, 2023

Nonalcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes (T2DM) Trial in Gainesville (Lanifibranor, Placebo)

Recruiting

Nonalcoholic Fatty Liver Disease (NAFLD)
Type 2 Diabetes (T2DM)

Lanifibranor
Placebo

Gainesville, Florida

University of Florida

Sep 20, 2022

Healthy Subjects Trial in Berlin (Moxifloxacin, Placebo, Lanifibranor)

Completed

Healthy Subjects

Moxifloxacin
+2 more

Berlin, Germany

Parexel International GmbH

Oct 31, 2019